A Grifols subsidiary and research and drug discovery company using plasma proteomics, AI, multiomics, and real-world data to identify disease biomarkers and develop potential plasma-derived therapies, particularly for neurodegenerative and age-related diseases
A Grifols subsidiary and research and drug discovery company using plasma proteomics, AI, multiomics, and real-world data to identify disease biomarkers and develop potential plasma-derived therapies, particularly for neurodegenerative and age-related diseases.